GVR Report cover In-vitro Fertilization Microscopes Market Size, Share & Trends Report

In-vitro Fertilization Microscopes Market Size, Share & Trends Analysis Report By End-use (Clinical, Academic Research), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-327-3
  • Number of Pages: 95
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Report Overview

The global in-vitro fertilization microscopes market size was valued at USD 94.0 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030. In-vitro fertilization microscopes are used for various procedures, such as semen analysis, oocyte preparation, in-vitro fertilization, and the overall analysis of the embryo. The improving success rate of in-vitro fertilization procedures and the availability of financial assistance are expected to boost the market growth. Furthermore, product innovations by manufacturers are increasing treatment efficiency and are expected to reduce procedure costs. Improved quality of microscopic examination by high contrast and innovations in the IVF microscope-related equipment are some of the important advancements in the market.

U.S. in-vitro fertilization microscopes market size, by end use, 2020 - 2030 (USD Million)

For instance, the Indian Institute of Technology (IIT) Hyderabad received funding from the Department of Science and Technology (DST), Government of India, for the development of an IoT-based 3D printed Time-lapse smart microscope for embryo monitoring in IVF clinics.

The removal of embryos from an optimized culture environment to inspect for cleavage and morphology increases stress, thus limiting the number of assessments that can be performed. The system used for embryo monitoring by time-lapse technology incorporates a microscope and camera inside the incubation system, which enables noninvasive microscopic imaging of the embryo at specific time intervals. In March 2019, Olympus Corporation and Jikei University School of Medicine collaborated to develop the AI-assisted sperm selection process to reduce the overall time required for Intracytoplasmic Sperm Injection (ICSI) procedure.

COVID-19 In-vitro fertilization microscopes market impact: 7.9% increase from 2020 to 2021

Pandemic Impact

Post COVID Outlook

Post the declaration of the COVID-19 pandemic by WHO, in March 2020, fertility organizations worldwide recommended ceasing IVF treatment, with the exception of essential medical fertility preservation. This led to a decrease in the number of patients opting for IVF treatments, in turn affecting the demand for consumables, devices, and services by fertility centers.

The relaxation in COVID-19 restrictions led to the reopening of IVF centers with measures such as ensuring adequate staff, decontamination and validation of equipment, and completion of risk assessment pertaining to viral contamination.

The COVID-19 pandemic has adversely affected the market owing to social distancing norms and delays in operations for the fertilization process. Since patients undergoing IVF needs to visit the clinic every week, IVF procedures were on halt during the pandemic period.

Digital health and telehealth adoption paved the way to overcome the negative impact of the COVID-19.


The rising prevalence of infertility among men and women is expected to foster the growth of the market for IVF microscopes during the forecast period. According to the World Health Organization data, approximately 186 million people and around 48 million couples are suffering from infertility globally. According to the US Society of Assisted Reproductive Technology (SART), approximately 0.29 million IVF cycles were initiated in the US in 2020.

The companies operating in the market for IVF microscopes have to follow the guidelines led by the authorities such as the American Society for Reproductive Medicine, the European Society of Human Reproduction and Embryology, and others. Considering the increasing awareness about IVF services, developing nations have also taken measures to introduce regulations. For instance, in India, the Assisted Reproductive Technology (Regulation) Act, 2008, categorizes infertility clinics into three levels and provides requirements they need to meet. It requires the embryology laboratory complex to house a stereo microscope, a micromanipulator for performing ICSI, and a high-resolution inverted microscope with Hoffman optics or phase contrast.

End-use Insights

The clinical segment dominated the market for IVF microscopes and accounted for the largest revenue share of 94.6% in 2021 and is expected to witness the fastest growth during the forecast period. Major factors contributing to the segment growth include increasing awareness regarding IVF treatment and growing investments by private investors in infertility clinics. The rising use of a variety of microscopes in clinical ART procedures is expected to boost the growth of the segment during the forecast period. Microscopes are used in clinical ART facilities to accomplish gamete selection and clinical procedures. Stereo microscopes are used to analyze oocyte and embryo morphology and viability, while upright microscopes are used to visualize and test sperm morphology, motility, and viability. While both types of microscopes are used in clinical settings, ones with an inverted design are the most adaptable for ART.

IVF clinics provide a range of services, including healthy oocyte identification, semen analysis, ICSI, embryo monitoring, and freezing and storage of embryos. There is a trend of innovating products for use in IVF clinics and receiving investments from private investors in IVF clinics. In November 2019, a fertility tech startup, Mojo, received funding of around USD 1.8 million. The startup is working on a combination of AI software and microscopy hardware, a product to assist in sperm selection by focusing on the count, morphology, and speed of the sperm.

Regional Insights

Europe dominated the in-vitro fertilization microscopes market and accounted for the largest revenue share of 24.5% in 2021 due to factors such as growing fertility tourism, legal reforms, and product innovation. The region has observed a significant adoption of time-lapse technology with clinic-designed algorithms. Innovation in microscopes providing all imaging requirements used in a single embryo chamber to reduce the requirement of multiple workstations is aiding in saving space and cost of the procedure.

Global in-vitro fertilization microscopes market, by region, 2021 (%)

Companies operating in the region are adopting various strategies including product launches, research initiatives, and others to propel the growth of the market for IVF microscopes during the forecast. For instance, in August 2021, Nikon Microscopes launched ECLIPSE Ti2-U IVF for the early procedures in the Intracytoplasmic Sperm Injection (ICSI). In Asia Pacific, the market for IVF microscopes is expected to witness the fastest growth over the forecast period owing to key factors such as increasing awareness and availability of IVF services. The presence of a large population and increasing awareness regarding IVF are among the key factors contributing to the increased demand for microscopes by clinics.

Key Companies & Market Share Insights

Established players are adopting strategies such as geographic expansion and product innovation by integrating the latest technology. For instance, in June 2020, Zeiss and Hamilton Throne joined the Global Fertility Alliance. Global Fertility Alliance is dedicated to assisting standardization of the processes required for the ART (Assisted Reproductive Treatment) laboratories. Merck KGaA, Illumina Inc., and Genea Limited are the existing members of the alliance. Some of the prominent players in the in-vitro fertilization microscopes market include:

  • Linkam Scientific Instruments

  • Olympus Corporation

  • Leica Microsystems

  • Meiji Techno

  • Zeiss

  • Euromex Microscopen B.V.

  • Labomed Europe B.V.

  • Nikon Corporation

  • Narishige Group

  • Eppendorf AG

  • Hamilton Thorne Ltd.

  • Sutter Instrument Company

  • Tritech Research, Inc.

 In-vitro Fertilization Microscopes Market Report Scope

Report Attribute


Market size value in 2022

USD 101.6 million

Revenue forecast in 2030

USD 193.2 million

Growth rate

CAGR of 8.4% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

End-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Mexico; Brazil; South Africa

Key companies profiled

Linkam Scientific Instruments; Olympus Corporation; Leica Microsystems; Meiji Techno; Zeiss; Euromex Microscopen B.V.; Labomed Europe B.V.; Nikon Corporation; Narishige Group; Eppendorf AG; Hamilton Thorne Ltd.; Sutter Instrument Company; Tritech Research, Inc.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global in-vitro fertilization microscopes market report on the basis of end-use and region:

  • End-use Outlook (Revenue, USD Million, 2017 - 2030)

    • Clinical

    • Academic Research

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Mexico

      • Brazil

    • Middle East & Africa (MEA)

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon